|(A;A)||1.5||2.5x increased odds of breast cancer among hormone-using postmenopausal women|
|(A;G)||1.5||2.5x increased odds of breast cancer among hormone-using postmenopausal women|
A study of 1,664 postmenopausal breast cancer cases and 2,391 controls led to two conclusions. First, women with at least one rs10895068(A) allele had a 1.3x (CI: 1.04-1.65) increased risk of developing breast cancer. Second, such carriers were at 2.57x (CI: 1.64-4.02) increased risk for breast cancer if they were never postmenopausal hormone users.[PMID 19462450]
2013 meta-analysis suggested association of weak effect with female reproductive (breast, endometrial and ovarian) cancer for A allele (A: OR = 1.063, 95% CI = 1.001-1.129; AA+AG: OR = 1.067, 95% CI = 1.002-1.136). A 2014 meta-analysis that looked only for association with ovarian cancer specifically found no significant association between rs10895068 and ovarian cancer - despite the study title claiming otherwise.
[PMID 24197980] Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
[PMID 23349706] Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.
[PMID 20076999] No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis
[PMID 20586553] Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis
[PMID 21086036] Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population
[PMID 21148628] Progesterone receptor gene variants and risk of endometrial cancer
[PMID 22121098] Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers
[PMID 16614108] Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
[PMID 16985038] PGR +331 A/G and increased risk of epithelial ovarian cancer.
[PMID 17592773] Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
[PMID 18219286] Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.
[PMID 18592033] Sex steroid-related candidate genes in psychiatric disorders.
[PMID 18628428] Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
[PMID 18805939] Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis.
[PMID 19382201] Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.
[PMID 19555469] A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.
[PMID 26694100] Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters.